
NeurologyLive® Friday 5 — February 6, 2026
Key Takeaways
- New AAN guidelines emphasize psychiatric assessment and seizure characterization for functional seizures, as discussed by Benjamin Tolchin, MD, FAAN.
- The REVISE trial investigates lenadogene nolparvovec gene therapy for Leber hereditary optic neuropathy, a rare genetic disorder causing vision loss.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 6, 2026.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
Click the read more buttons for more details and information about each highlight.
1: Women Physicians Day 2026: Supporting Women With MS Through Reproductive and Life Stage Transitions
In this exclusive NeurologyLive Q&A feature, Katrina Bawden, MSN, MSCN, FNP-C, April Erwin, MD, and Parisa Khosravi, DO, highlighted the importance of individualized care for women living with multiple sclerosis, in honor of National Women Physicians Day, held February 3, 2026.
2: Advice and Reflections from the Dravet Syndrome Journey
In this NeurologyLive Cure Connections episode, Joseph Sullivan, MD, Ross Nicholas, Michael Chieco, and Kristen Coombe shared valuable insights and support for families navigating Dravet syndrome, emphasizing community connection and self-care for a hopeful journey.
3: Women Physicians Day 2026: Prioritizing Whole-Person Care for Women With Movement Disorders
In this exclusive NeurologyLive Q&A feature, Jill Farmer, DO, MPH, FCPP, DipABLM; Kelly Papesh, DNP, APRN, FNP-C, CMRD; Madhureeta Achari, MD; and Joanna Dearlove, MD, discussed various topics in the care for women with movement disorders, as part of National Women Physicians Day.
4: NeuroVoices: Benjamin Tolchin, MD, FAAN, on First-Ever AAN Guidelines for Functional Seizures
In our latest NeuroVoices Q&A, Benjamin Tolchin, MD, FAAN, director of the Center for Clinical Ethics at Yale New Haven Health, discussed the rationale behind the newly published AAN guidelines on functional seizures, outlining diagnostic priorities, evidence-based treatment recommendations, and key gaps.
5: Epilepsy Surgery and Neurostimulation in the Adult DEE Population
In this NeurologyLive Insights episode, Joseph Sullivan, MD, discussed the evolving role of neurostimulation and surgery in managing drug-resistant epilepsies in adults, highlighting both practical limitations and emerging evidence.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.










